Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stéphane Chèze

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Joint Bone Spine|September 25, 2012
Eosinophilic fasciitis with paroxysmal nocturnal hemoglobinuriaHubert de Boysson, Stéphane Chèze, Françoise Chapon, et al.
Cancers|February 25, 2022
Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) DisordersElsa Maitre, Edouard Cornet, Véronique Salaün, et al.
Bulletin Du Cancer|March 30, 2019
[Antineoplastic drug induced nausea and vomiting: What is the clinical practice in 2018? An update of AFSOS clinical guidelines]Nicolas Jovenin, Audrey Eche-Gass, Stéphane Chèze, et al.
Lancet (London, England)|January 26, 2002
Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trialBertrand Godeau, Sylvie Chevret, Bruno Varet, et al.
British Journal of Haematology|January 24, 2024
Difficult-to-treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN-France registryGuillaume Moulis, Manuela Rueter, Aymeric Duvivier, et al.
American Journal of Hematology|January 8, 2026
Real-World Effectiveness and Safety of Fostamatinib in Difficult-to-Treat Immune Thrombocytopenia Patients. A Prospective, Multicenter Registry in FranceGuillaume Moulis, Matthieu Mahévas, Jean-François Viallard, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Joint Bone Spine|September 25, 2012
Eosinophilic fasciitis with paroxysmal nocturnal hemoglobinuriaHubert de Boysson, Stéphane Chèze, Françoise Chapon, et al.
Cancers|February 25, 2022
Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) DisordersElsa Maitre, Edouard Cornet, Véronique Salaün, et al.
Bulletin Du Cancer|March 30, 2019
[Antineoplastic drug induced nausea and vomiting: What is the clinical practice in 2018? An update of AFSOS clinical guidelines]Nicolas Jovenin, Audrey Eche-Gass, Stéphane Chèze, et al.
Lancet (London, England)|January 26, 2002
Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trialBertrand Godeau, Sylvie Chevret, Bruno Varet, et al.
British Journal of Haematology|January 24, 2024
Difficult-to-treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN-France registryGuillaume Moulis, Manuela Rueter, Aymeric Duvivier, et al.
American Journal of Hematology|January 8, 2026
Real-World Effectiveness and Safety of Fostamatinib in Difficult-to-Treat Immune Thrombocytopenia Patients. A Prospective, Multicenter Registry in FranceGuillaume Moulis, Matthieu Mahévas, Jean-François Viallard, et al.
Pageof 1